Significant Valvular Dysfunction and Outcomes in Cardiogenic Shock: Insights From the Randomized DOREMI TrialSimon Parlow, Benjamin Hibbert, Trevor Simard et al.|Canadian Journal of Cardiology|2022Cited by 19
Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trialSimon Parlow, Rebecca Mathew, Pietro Di Santo et al.|American Heart Journal|2023Cited by 17
Inhaled anaesthesia compared with conventional sedation in post cardiac arrest patients undergoing temperature control: A systematic review and meta-analysisSimon Parlow, Rebecca Mathew, Melissa Fay Lepage-Ratte et al.|Resuscitation|2022Cited by 10
Implications of Different Etiologies of Ventricular Dysfunction and Outcome in Cardiogenic Shock: A Subgroup Analysis of the CAPITAL-DOREMI TrialRebecca Mathew, Benjamin Hibbert, Melissa Fay Lepage-Ratte et al.|SSRN Electronic Journal|2022Cited by 0